tiprankstipranks
Trending News
More News >
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Advertisement

Keros Therapeutics (KROS) Similar Stocks

Compare
347 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Keros Therapeutics
$14.49
$588.52M
46.25
-76.28%
3 Buy
4 Hold
0 Sell
Moderate Buy
Gyre Therapeutics
$8.87
$805.63M
544.17
-37.66%
3 Buy
0 Hold
0 Sell
Strong Buy
KalVista Pharmaceuticals
$11.94
$603.25M
-1.24%
8 Buy
0 Hold
0 Sell
Strong Buy
Palvella Therapeutics
$76.31
$843.96M
362.77%
12 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$10.35
$795.74M
-58.13%
8 Buy
2 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$18.81
$1.03B
-7.97%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KROS
Keros Therapeutics
14.49
-46.60
-76.28%
GYRE
Gyre Therapeutics
8.74
-5.28
-37.66%
KALV
KalVista Pharmaceuticals
11.94
-0.15
-1.24%
PVLA
Palvella Therapeutics
76.31
59.38
350.74%
NRIX
Nurix Therapeutics
10.35
-14.37
-58.13%
BCAX
Bicara Therapeutics Inc.
18.81
-1.63
-7.97%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis